Selected article for: "benefit risk and short course"

Author: McCreary, Erin K; Pogue, Jason M
Title: Coronavirus Disease 2019 Treatment: A Review of Early and Emerging Options
  • Document date: 2020_3_23
  • ID: j0i9ozsz_44
    Snippet: Appropriate management strategies for patients with COVID-19 are a rapidly evolving therapeutic challenge, and the optimal agents (if any) to treat infection or prevent progression to critical illness remain ill-defined. Although certain agents listed in this review are encouraging, and the potential benefit of therapy likely outweighs the relatively minor risk of adverse events from short-course therapy, the evidence remains inconclusive and cha.....
    Document: Appropriate management strategies for patients with COVID-19 are a rapidly evolving therapeutic challenge, and the optimal agents (if any) to treat infection or prevent progression to critical illness remain ill-defined. Although certain agents listed in this review are encouraging, and the potential benefit of therapy likely outweighs the relatively minor risk of adverse events from short-course therapy, the evidence remains inconclusive and changes almost daily.

    Search related documents:
    Co phrase search for related documents
    • adverse event and daily change: 1
    • adverse event and infection treat: 1, 2
    • adverse event and management strategy: 1
    • adverse event and potential benefit: 1, 2, 3, 4, 5, 6
    • adverse event and progression prevent: 1, 2, 3
    • adverse event and therapeutic challenge: 1
    • adverse event and therapy potential benefit: 1
    • certain agent and critical illness: 1
    • critical illness and infection treat: 1
    • critical illness and management strategy: 1, 2, 3
    • critical illness and potential benefit: 1, 2, 3
    • critical illness and progression prevent: 1, 2
    • critical illness and rapidly evolve: 1
    • critical illness and therapeutic challenge: 1
    • critical illness and therapy potential benefit: 1